Prevalence and detection of metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa strains from clinical isolates in Iran

Annals of Microbiology

Volumn 57, Issue 2, 2007, Pages 293-295

  Yazdi, Hadi Rezaei ^a   Nejad, Ghorban Behzadian ^a   Peerayeh, Shahin Najar ^a   Mostafaei, Mohammad ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Etest MBL; MBL; Metallo lactamase; Pseudomonas aeruginosa; VIM

Indexed keywords

PSEUDOMONAS AERUGINOSA;

EID: 34547199979     PISSN: 15904261     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03175223     Document Type: Article

References (13)

1. Bush K., Jacoby G.A., Medeiros A.A. (1995). A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Ag. Chemother., 39: 1211-1233.
2. Kohler T., Michea-Hamzehpour T., Simone F.E., Pechere J.C. (1999). Carbapenems activities against Pseudomonas aeruginosa: respective contribution of OprD and efflux systems. Antimicrob. Ag. Chemother., 43: 424-427.
3. Lauretti L., Riccio M.L., Mazzariol A., Cornaglia G., Amicosante G., Fontana R., Rossolini G.M. (1999).Cloning and characterization of bla VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Ag. Chemother., 43: 1584-1590.
4. Li X.Z., Nikaido H., Poole K. (1995). Role of MexA-MexB-OprM in antibiotic efflux system in Pseudomonas aeruginosa. Antimicrob. Ag. Chemother., 39: 1948-1953.
5. Livermore D.M. (1992). Carbapenemases. J. Antimicrob. Chemother., 29: 609-616.
6. Luzzaro F., Endimiani A., Docquier J.D., Mugnaioli C., Bonsignori M., Amicosante G., Rossolini G.M., Toniolo A. (2004). Prevalence and characterization of metallo-β-lactamases in clinical isolates of Pseudomonas aeruginosa. Diag. Microb. Infect. Dis., 48: 131-135.
7. Morrison A.J.Jr, Wenzel R.P. (1984). Epidemiology of infection due to Pseudomonas aeruginosa. Rev. Infect. Dis., 6: 627-642.
8. National Committee for Clinical Laboratory Standards (2003). Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard M7-A6. NCCLS, Villanova, PA, USA.
9. Nordmann P., Poirel L. (2002). Emerging carbapenemases in Gram negative aerobes. Clin. Microbiol. Infect., 8: 321-331.
10. Poirel L., Naas T., Nicolas D., Collect L., Bellais S., Cavallo J.D., Nordmann P. (2000). Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid and integran borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Ag. Chemother., 44: 891-897.
11. Quinn J.P., Studemeister A.E., Divincenzo C.A. et al. (1988). Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms. Rev. Infect. Disease., 10: 892-898.
12. Senda K., Arakawa Y., Nakashima K., Ito H., Ichiyama S., Shimokata K., Kato N., Ohata M. (1996). Multifocal out-breaks of metallo-β-lactamase producing Pseudomonas aeruginosa resistant to broad-spectrum including carbapenems. Antimicrob. Ag. Chemother., 40: 349-353.
13. Walsh T.R., Bolmstrom A., Gales A. (2002). Evaluation of a new Etest for detecting metallo-β-lactamases in routine clinical testing. J. Clin. Micribiol., 40: 2755-2759.